Semler Scientific Inc
NASDAQ:SMLR
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
21.03
66.43
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Gross Margin
Semler Scientific Inc
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Gross Margin Across Competitors
Country | US |
Market Cap | 453.2m USD |
Gross Margin |
88%
|
Country | US |
Market Cap | 204.9B USD |
Gross Margin |
56%
|
Country | US |
Market Cap | 195.2B USD |
Gross Margin |
67%
|
Country | US |
Market Cap | 146.7B USD |
Gross Margin |
64%
|
Country | US |
Market Cap | 132.6B USD |
Gross Margin |
69%
|
Country | IE |
Market Cap | 110.6B USD |
Gross Margin |
66%
|
Country | US |
Market Cap | 64.7B USD |
Gross Margin |
45%
|
Country | DE |
Market Cap | 55.6B EUR |
Gross Margin |
38%
|
Country | CN |
Market Cap | 319.2B CNY |
Gross Margin |
65%
|
Country | US |
Market Cap | 41.6B USD |
Gross Margin |
79%
|
Country | US |
Market Cap | 37.7B USD |
Gross Margin |
41%
|
Semler Scientific Inc
Glance View
Semler Scientific, Inc. engages in the provision of technology and software solutions to improve the clinical effectiveness of healthcare providers. The company is headquartered in Santa Clara, California and currently employs 124 full-time employees. The company went IPO on 2014-02-27. The firm develops, manufactures, and markets products and services that assist its customers in evaluating and treating chronic diseases. Its vascular testing product, QuantaFlo, measures arterial blood flow in the extremities to aid in the diagnosis of peripheral arterial disease (PAD). QuantaFlo is a four-minute in-office blood flow test. Healthcare providers can use blood flow measurements as part of their examinations of a patient's vascular condition, including assessments of patients who have vascular disease. The company also has a distribution arrangement for the United States, including Puerto Rico, to distribute Insulin Insights, a software solution designed to provide insulin dosing recommendations to clinicians for the adjustment and maintenance of blood. The firm's customers for QuantaFlo include insurance plans, physician groups, and risk assessment groups.
See Also
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Based on Semler Scientific Inc's most recent financial statements, the company has Gross Margin of 88.1%.